P00720 (ENLYS_BPT4) Enterobacteria phage T4 (Bacteriophage T4)

Endolysin UniProtKBProtein AtlasInterProInteractive Modelling

164 aa; Sequence (Fasta)

Available Structures

755 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Application of anti-helix antibodies in protein structure determination (9213-3LRH) Heteromer
1-164
95.73
Crystal structure of SIV Vpr,fused to T4 lysozyme, isolated from moustached monkey, bound to human … Heteromer
A4UDG5; Q16531; Q9Y4B6;
2-164
96.93GOL;ZN;
Structure of a cytoplasmic 11-subunit RNA exosome complex including Ski7, bound to RNA Heteromer
P25359; P38792; P46948; P48240; P53256; P53859; Q05636; Q08162; Q08285; Q08491; Q12277;
1-163
98.04MPD;NA;ZN;
Complex of SpaO(SPOA1,2) and OrgB(APAR)::T4lysozyme fusion protein Heteromer
P0CL45; P40699;
2-163
95.68
Complex of SpaO(SPOA1,2 SeMet) and OrgB(APAR)::T4lysozyme fusion protein Heteromer
P0CL45; P40699;
2-163
95.52
crystal structure of mitochondrial calcium uptake 2(MICU2) Heteromer
Q8IYU8;
1-161
98.76CA;
Structure of the 2TEL crystallization module fused to T4 lysozyme with a helical linker. Heteromer
P41212;
2-162
96.89NO3;NH4;
Structure of the 2TEL crystallization module fused to T4 lysozyme with an Ala-Gly-Pro linker. Heteromer
P41212;
2-162
96.27MN;
The crystal structure of an engineered phage lysin containing the binding domain of pesticin and th… Heteromer
Q57159;
3-163
99.27
Crystal structure of human claudin-4 in complex with C-terminal fragment of Clostridium perfringens… Heteromer
O14493; P01558;
2-162
97.5
Complex of FliM(SPOA)::FliN fusion protein and FliH(APAR)::T4lysozyme fusion protein Heteromer
P26418; P26419;
2-161
97.5
Structure of active-like neurotensin receptor Heteromer
P20068; P20789;
2-161
96.25CIT;PEG;GOL;EPE;
Structure of beta2 adrenoceptor bound to BI167107 and an engineered nanobody Heteromer
P07550;
2-161
97.5P0G;NA;1WV;
Crystal structure of the KAP1 tripartite motif in complex with the ZNF93 KRAB domain Heteromer
P35789; Q13263; Q9H4L7;
2-161
100ZN;
Human endothelin receptor type-B in complex with ET-1 Heteromer
P05305; P24530;
2-161
97.5
The crystal structure of the neurotensin receptor NTS1 in complex with neurotensin (8-13) Heteromer
P20068; P20789;
2-161
96.18EPE;
Structure of active-like neurotensin receptor Heteromer
P20068; P20789;
2-161
96.251PE;EPE;FLC;PEG;
Crystal structure of human beta2 adrenergic receptor bound to salmeterol and Nb71 Heteromer
P07550;
2-161
97.5K5Y;MG;NI;OLC;HTO;OLA;P33;
The beta2 adrenergic receptor bound to a bitopic ligand Heteromer
P07550;
2-161
97.48A1AE2;AV0;
Structure of the Full-length glucagon class B G protein-coupled receptor Heteromer
P47871;
2-161
98.08NAG;NAG;97V;
Structure of the glucagon receptor in complex with a glucagon analogue Heteromer
P01275; P47871;
2-161
97.5NAG;OLC;PO4;
Structure of beta2 adrenoceptor bound to hydroxybenzylisoproterenol and an engineered nanobody Heteromer
P07550;
2-161
97.5XQC;NA;1WV;
Crystal structure of CXCR4 and viral chemokine antagonist vMIP-II complex (PSI Community Target) Heteromer
P61073; Q98157;
2-161
97.5
Crystal structure of the CXCR4 chemokine receptor in complex with a small molecule antagonist IT1t … Heteromer
P61073;
2-161
97.5ITD;
Crystal structure of the chemokine CXCR4 receptor in complex with a small molecule antagonist IT1t … Heteromer
P61073;
2-161
97.45ITD;
Structure of the Full-length glucagon class B G protein-coupled receptor Heteromer
P47871;
2-161
98.06NAG;97V;
Crystal structure of the beta2 adrenergic receptor-Gs protein complex Heteromer
P04896; P07550; P54311; P63212;
2-161
97.48P0G;
Structure of beta2 adrenoceptor bound to carazolol and inactive-state stabilizing nanobody, Nb60 Heteromer
P07550;
2-161
98.09CAU;CLR;
Structure of beta2 adrenoceptor bound to adrenaline and an engineered nanobody Heteromer
P07550;
2-161
97.51WV;ALE;NA;
Structure of beta2 adrenoceptor bound to a covalent agonist and an engineered nanobody Heteromer
P07550;
2-161
97.5NA;35V;
STRUCTURE OF CONSTITUTIVELY ACTIVE NEUROTENSIN RECEPTOR Heteromer
P20068; P20789;
2-161
96.25TCE;GOL;PEG;
N-Terminal T4 Lysozyme Fusion Facilitates Crystallization of a G Protein Coupled Receptor Heteromer
P07550;
2-161
97.5CAU;
Crystal structure of the human platelet-activating factor receptor in complex with ABT-491 Heteromer
P25105;
61-161
98.09EU;OLC;ZN;SO4;
Zn-mediated Hexamer of T4 Lysozyme R76H/R80H by Synthetic Symmetrizationhomo-6-mer1-162
96.27ZN;CL;
Disulphide-mediated Tetramer of T4 Lysozyme R76C/R80C by Synthetic Symmetrizationhomo-4-mer1-162
96.312×CL;
Zn-mediated Trimer of T4 Lysozyme R125C/E128C by Synthetic Symmetrizationhomo-3-mer1-162
96.3ZN;CL;MG;GOL;
Cu-mediated Trimer of T4 Lysozyme D61H/K65H/R76H/R80H by Synthetic Symmetrizationhomo-3-mer1-162
95.06CU;
Crystal structure of T4 Lysozyme S44C synthetic dimerhomo-2-mer1-164
96.95SO4;GOL;
Crystal structure of T4 Lysozyme V131C synthetic dimerhomo-2-mer1-164
96.95SO4;
Crystal structure of T4 Lysozyme D72C synthetic dimerhomo-2-mer1-164
96.95TRS;
Structure of the BBox-Coiled-coil region of Rhesus Trim5alphahomo-2-mer2-164
96.93ZN;
Crystal Structure of T4 lysozyme with the unnatural amino acid p-Acetyl-L-Phenylalanine incorporate…homo-2-mer1-162
95.68AZI;CL;
Wild type T4 lysozyme structurehomo-2-mer1-162
98.77SO4;EPE;CL;GOL;
Cu-mediated Dimer of T4 Lysozyme R76H/R80H by Synthetic Symmetrizationhomo-2-mer1-162
96.3FMT;CU;
Cu-mediated Dimer of T4 Lysozyme D61H/K65H by Synthetic Symmetrizationhomo-2-mer1-162
96.3CU;
Cu-mediated Dimer of T4 Lysozyme D61H/K65H/R76H/R80H by Synthetic Symmetrizationhomo-2-mer1-162
95.06CU;CL;
The crystal structure of pesticin-T4 lysozyme hybrid stabilized by engineered disulfide bondshomo-2-mer4-164
87.5SO4;NA;
The 2.5 A structure of the CXCR4 chemokine receptor in complex with small molecule antagonist IT1thomo-2-mer2-161
97.5ITD;OLC;OLA;
Crystal structure of the mu-opioid receptor bound to a morphinan antagonisthomo-2-mer2-161
96.88BF0; 24×SO4;CLR;MPG;1PE;CL;
Structure of the human kappa opioid receptor in complex with JDTichomo-2-mer2-161
97.5JDC;CIT;OLC;PEG;
Crystal Structure of Saccharomyces cerevisiae Upc2 Transcription Factor fused with T4 Lysozymehomo-2-mer2-161
97.5
Crystal structure of the CXCR4 chemokine receptor in complex with a cyclic peptide antagonist CVX15homo-2-mer2-161
97.5
Structure of the tripartite motif of KAP1/TRIM28homo-2-mer2-161
100ZN;
Crystal structure of the CXCR4 chemokine receptor in complex with a small molecule antagonist IT1t …homo-2-mer2-161
97.3ITD;OLC;GOL;
Structure of the ligand-binding domain of S. cerevisiae Upc2 in fusion with T4 lysozymehomo-2-mer2-161
97.11
Crystal structure of rhodopsin bound to visual arrestinhomo-2-mer2-161
97.5
T4 lysozyme C-terminal fragmentmonomer1-164
97.11ACT;CL;
Structure of Spin-labelled T4 lysozyme mutant L118C-R1 at 100Kmonomer1-164
96.95MTN;CL;BME;AZI;K;
High-resolution X-ray structure of the T26H mutant of T4 lysozymemonomer1-164
96.95NA;CL;HEZ;GOL;
Structure of (3S,4S)-1-benzyl-4-(3-(3-(trifluoromethyl)phenyl)ureido)piperidin-3-yl acetate bound t…monomer1-164
96.95DOJ;
Use of a Halide Binding Site to Bypass the 1000-atom Limit to Ab initio Structure Determinationmonomer1-164
97.56RB;CL;BME;
Use of an ion-binding site to bypass the 1000-atom limit to ab initio structure determination by di…monomer1-164
97.56PO4;RB;CL;BME;
Use of an ion-binding site to bypass the 1000-atom limit to ab initio structure determination by di…monomer1-164
97.56RB;CL;BME;
Use of a Halide Binding Site to Bypass the 1000-atom Limit to Structure Determination by Direct Met…monomer1-164
97.56RB;CL;BME;
Evaulaution at Atomic Resolution of the Role of Strain in Destabilizing the Temperature Sensitive T…monomer1-164
98.17HED;PO4;CL;NA;K;
Structure of 1-(benzo[d][1,3]dioxol-5-ylmethyl)-1-(1-propylpiperidin-4-yl)-3-(3-(trifluoromethyl)ph…monomer1-164
96.95DQD;
Structure of Spin-labelled T4 lysozyme mutant L115C-R119C-R1 at 100Kmonomer1-164
96.34RXR;CL;HED;PO4;BME;K;
Evaulaution at Atomic Resolution of the Role of Strain in Destabilizing the Temperature Sensitive T…monomer1-164
97.56PO4;BME;
Polar and non-polar cavities in phage T4 lysozymemonomer1-164
96.34K;CL;AZI;EPE;BME;HED;GOL;
New azaborine compounds bind to the T4 lysozyme L99A cavity - Benzene as controlmonomer1-164
96.95HED;PO4;BNZ;
New azaborine compounds bind to the T4 lysozyme L99A cavity - 1,2-dihydro-1,2-azaborinemonomer1-164
96.95HED;PO4;NA;B20;
New azaborine compounds bind to the T4 lysozyme L99A cavity - 1-ethyl-2-hydro-1,2-azaborinemonomer1-164
96.95HED;NA;PO4;B24;
T4 Lysozyme L99A - 4-iodotoluene - cryomonomer1-164
98.17TRS;BME;CA;XQM;
T4 Lysozyme L99A/M102H with 2-Mercaptoethanol Boundmonomer1-164
93.9BME;SO4;HED;
Structure of DCN1 bound to NAcM-OPTmonomer1-164
95.738ZA;
T4 Lysozyme L99A with n-Hexylbenzene Boundmonomer1-164
98.173GZ;EPE;
Structure of Spin-labeled T4 Lysozyme Mutant T115R7monomer1-164
96.95R7A;BME;
New strategy to analyze structures of glycopeptide antibiotic-target complexesmonomer1-164
96.95BGC;MPD;MRD;PO4;TRS;CL;IPA;
Structure of Spin labeled T4 Lysozyme Mutant T115R1Amonomer1-164
96.95MTN;
T4 LYOSZYME CORE REPACKING MUTANT I100V/TAmonomer1-164
96.95K;CL;BME;
High resolution crystal structure of T4 lysozyme mutant L20R63/A liganded to guanidinium ionmonomer1-164
96.34CL;GAI;HED;
T4 Lysozyme L99A with No Ligand Boundmonomer1-164
98.17EPE;
Multiple methionine substitutions are tolerated in T4 lysozyme and have coupled effects on folding …monomer1-164
97.56K;CL;HED;
Spin-Labeled T4 Lysozyme Construct K43V1monomer1-164
96.95V1A;CL;PO4;K;HEZ;
Spin-Labeled T4 Lysozyme Construct R119V1monomer1-164
96.95PO4;CL;K;V1A;
Spin-Labeled T4 Lysozyme Construct I9V1/V131V1 (30 days)monomer1-164
96.34V1A;HEZ;CL;K;
T4 Lysozyme L99A/M102H with 2-allylphenol boundmonomer1-164
93.9BME;2LP;SO4;HED;
T4 Lysozyme L99A/M102H with 2-Cyanophenol Boundmonomer1-164
93.9BME;0R0;SO4;ACT;HED;
T4 LYSOZYME CORE REPACKING MUTANT V103I/TAmonomer1-164
96.95
T4 Lysozyme L99A with Benzene Boundmonomer1-164
98.17BNZ;EPE;
T4 Lysozyme L99A/M102H with phenol boundmonomer1-164
93.9BME;IPH;SO4;ACT;HED;
T4 Lysozyme Core Repacking Mutant V149I/T152V/TAmonomer1-164
96.34PO4;K;CL;HED;
T4 Lysozyme L99A/M102H with 2-(pyrazolo-1-yl) ethanol boundmonomer1-164
93.9BME;1DU;SO4;ACT;HED;
Crystal Structure of T4 Lysozyme Mutant R96Wmonomer1-164
98.17CL;NA;IPA;
Spin-Labeled T4 Lysozyme Construct V131V1monomer1-164
96.95CL;K;V1A;PO4;
Spin-Labeled T4 Lysozyme Construct I9V1monomer1-164
96.95CL;K;V1A;PO4;
T4 Lysozyme L99A/M102H with 4-Nitrophenol Boundmonomer1-164
93.9BME;NPO;SO4;HED;
T4 LYSOZYME CORE REPACKING MUTANT M120Y/TAmonomer1-164
96.95PO4;K;CL;HED;
CORE REDESIGN BACK-REVERTANT I103V/CORE10monomer1-164
92.07PO4;K;CL;HED;
T4 Lysozyme L99A/M102H with 2-bromo-5-hydroxybenzaldehyde boundmonomer1-164
93.9BME;1DW;SO4;ACT;HED;
Structure of Spin-labeled T4 Lysozyme Mutant T115R1/R119Amonomer1-164
96.34MTN;
T4 Lysozyme L99A with Toluene Boundmonomer1-164
98.17MBN;EPE;
T4 LYSOZYME CORE REPACKING MUTANT I118L/CORE7/TAmonomer1-164
93.9K;CL;BME;
T4 LYSOZYME CORE REPACKING BACK-REVERTANT L102M/CORE10monomer1-164
92.07K;CL;HED;
T4 Lysozyme Core Repacking Mutant V87I/TAmonomer1-164
96.95PO4;K;CL;HED;
T4 Lysozyme L99A/M102H with 1-phenyl-2-propyn-1-ol boundmonomer1-164
93.9BME;1DJ;SO4;HED;
T4 Lysozyme L99A/M102H with 4-trifluoromethylimidazole boundmonomer1-164
93.9BME;1DQ;SO4;ACT;HED;
T4 LYSOZYME CORE REPACKING MUTANT I78V/TAmonomer1-164
96.95K;CL;HED;
T4 Lysozyme L99A/M102H with 4-bromoimidazole boundmonomer1-164
93.9BME;ES3;SO4;HED;
Crystal structure of spin labeled T4 Lysozyme (V131R1F)monomer1-164
96.95R1F;CL;
Structure of DCN1 bound to NAcM-COVmonomer1-164
95.738ZD;
Structure of Spin-labelled T4 lysozyme mutant L118C-R1 at Room Temperaturemonomer1-164
96.95MTN;HED;CL;NA;
T4 LYSOZYME CORE REPACKING MUTANT L133F/TAmonomer1-164
96.95K;CL;HED;
T4 Lysozyme L99A with sec-Butylbenzene Boundmonomer1-164
98.173GY;EPE;
Contributions of all 20 amino acids at site 96 to the stability and structure of T4 lysozymemonomer1-164
98.17CL;BME;
X-ray structure of perdeuterated T4 lysozyme cysteine-free pseudo-wild type at cryogenic temperaturemonomer1-164
97.56PO4;NA;HED;CL;GOL;
T4 Lysozyme L99A/M102H with Nitrobenzene Boundmonomer1-164
93.9BME;NBZ;SO4;ACT;
Contribution of all 20 amino acids at site 96 to the stability and structure of T4 lysozymemonomer1-164
98.17K;CL;BME;
T4 Lysozyme L99A/M102H with Isoxazole Boundmonomer1-164
93.9BME;0R1;SO4;ACT;
T4 Lysozyme L99A with n-Propylbenzene Boundmonomer1-164
98.173H0;EPE;
T4 LYSOZYME CORE REPACKING MUTANT CORE10/TAmonomer1-164
91.46K;CL;BME;
T4 Lysozyme Core Repacking Mutant L118I/TAmonomer1-164
96.95K;CL;HED;
Free of ligand binding in the hydrophobic cavity of T4 lysozyme L99A mutantmonomer1-164
96.95PO4;CL;HED;BME;
ANALYSIS OF THE INTERACTION BETWEEN CHARGED SIDE CHAINS AND THE ALPHA-HELIX DIPOLE USING DESIGNED T…monomer1-164
98.17BME;
PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYMEmonomer1-164
97.56HED;
T4 lysozyme core repacking mutant M106I/TAmonomer1-164
96.95K;CL;HED;
T4 Lysozyme L99A/M102H with benzene boundmonomer1-164
93.86BME;BNZ;SO4;ACT;HED;
T4 lysozyme mutant D89A/R96H at room temperaturemonomer1-164
97.56CL;BME;
Contributions of all 20 amino acids at site 96 to the stability and structure of T4 lysozymemonomer1-164
98.17CL;K;BME;
Contributions of all 20 amino acids at site 96 to the stability and structure of T4 lysozymemonomer1-164
98.17CL;K;BME;
Bacteriophage lysozyme T4 lysozyme mutant K85A/R96Hmonomer1-164
97.56CL;BME;
T4 Lysozyme L99A with n-Butylbenzene Boundmonomer1-164
98.17N4B;EPE;
T4 Lysozyme L99A/M102H with 3-trifluoromethyl-5-methyl pyrazole boundmonomer1-164
93.9BME;1DV;SO4;ACT;HED;
CUMULATIVE SITE-DIRECTED CHARGE-CHANGE REPLACEMENTS IN BACTERIOPHAGE T4 LYSOZYME SUGGEST THAT LONG-…monomer1-164
98.17
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE…monomer1-164
96.95CL;HED;
STRUCTURE OF BACTERIOPHAGE T4 LYSOZYME REFINED AT 1.7 ANGSTROMS RESOLUTIONmonomer1-164
98.78
STRUCTURAL STUDIES OF MUTANTS OF T4 LYSOZYME THAT ALTER HYDROPHOBIC STABILIZATIONmonomer1-164
98.78
R96Q Mutant of wildtype phage T4 lysozyme at 298 Kmonomer1-164
98.17CL;HED;
Crystal structure of spin labeled T4 Lysozyme (V131R7)monomer1-164
96.95R7A;AZI;CL;HED;
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYMEmonomer1-164
98.17
HYDROPHOBIC STABILIZATION IN T4 LYSOZYME DETERMINED DIRECTLY BY MULTIPLE SUBSTITUTIONS OF ILE 3monomer1-164
98.17
ANALYSIS OF THE INTERACTION BETWEEN CHARGED SIDE CHAINS AND THE ALPHA-HELIX DIPOLE USING DESIGNED T…monomer1-164
98.17
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYMEmonomer1-164
98.17
STRUCTURAL ANALYSIS OF THE TEMPERATURE-SENSITIVE MUTANT OF BACTERIOPHAGE T4 LYSOZYME, GLYCINE 156 (…monomer1-164
98.17
REPLACEMENTS OF PRO86 IN PHAGE T4 LYSOZYME EXTEND AN ALPHA-HELIX BUT DO NOT ALTER PROTEIN STABILITYmonomer1-164
98.17BME;
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYMEmonomer1-164
98.17BME;
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYMEmonomer1-164
98.17
ENHANCED PROTEIN THERMOSTABILITY FROM SITE-DIRECTED MUTATIONS THAT DECREASE THE ENTROPY OF UNFOLDINGmonomer1-164
98.17
CONTRIBUTIONS OF LEFT-HANDED HELICAL RESIDUES TO THE STRUCTURE AND STABILITY OF BACTERIOPHAGE T4 LY…monomer1-164
98.17
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYMEmonomer1-164
98.17
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYMEmonomer1-164
98.17
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYMEmonomer1-164
98.17
ENHANCED PROTEIN THERMOSTABILITY FROM SITE-DIRECTED MUTATIONS THAT DECREASE THE ENTROPY OF UNFOLDINGmonomer1-164
98.17
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYMEmonomer1-164
98.17
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYMEmonomer1-164
98.17
STRUCTURAL AND THERMODYNAMIC ANALYSIS OF THE PACKING OF TWO ALPHA-HELICES IN BACTERIOPHAGE T4 LYSOZ…monomer1-164
98.17
CUMULATIVE SITE-DIRECTED CHARGE-CHANGE REPLACEMENTS IN BACTERIOPHAGE T4 LYSOZYME SUGGEST THAT LONG-…monomer1-164
98.17
Xray crystal structure of T4 lysozyme mutant L20/R63A liganded to methylguanidiniummonomer1-164
96.34CL;MGX;BME;
CUMULATIVE SITE-DIRECTED CHARGE-CHANGE REPLACEMENTS IN BACTERIOPHAGE T4 LYSOZYME SUGGEST THAT LONG-…monomer1-164
98.17
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYMEmonomer1-164
98.17
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYMEmonomer1-164
98.17
CONTRIBUTIONS OF LEFT-HANDED HELICAL RESIDUES TO THE STRUCTURE AND STABILITY OF BACTERIOPHAGE T4 LY…monomer1-164
98.17
REPLACEMENTS OF PRO86 IN PHAGE T4 LYSOZYME EXTEND AN ALPHA-HELIX BUT DO NOT ALTER PROTEIN STABILITYmonomer1-164
98.17
STRUCTURAL STUDIES OF MUTANTS OF THE LYSOZYME OF BACTERIOPHAGE T4. THE TEMPERATURE-SENSITIVE MUTANT…monomer1-164
97.56
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYMEmonomer1-164
98.17BME;
CUMULATIVE SITE-DIRECTED CHARGE-CHANGE REPLACEMENTS IN BACTERIOPHAGE T4 LYSOZYME SUGGEST THAT LONG-…monomer1-164
98.17
STRUCTURAL STUDIES OF MUTANTS OF THE LYSOZYME OF BACTERIOPHAGE T4. THE TEMPERATURE-SENSITIVE MUTANT…monomer1-164
98.17
REPLACEMENTS OF PRO86 IN PHAGE T4 LYSOZYME EXTEND AN ALPHA-HELIX BUT DO NOT ALTER PROTEIN STABILITYmonomer1-164
98.17
HYDROPHOBIC STABILIZATION IN T4 LYSOZYME DETERMINED DIRECTLY BY MULTIPLE SUBSTITUTIONS OF ILE 3monomer1-164
98.17
STRUCTURAL AND THERMODYNAMIC ANALYSIS OF THE PACKING OF TWO ALPHA-HELICES IN BACTERIOPHAGE T4 LYSOZ…monomer1-164
98.17BME;
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYMEmonomer1-164
98.17
ENHANCED PROTEIN THERMOSTABILITY FROM DESIGNED MUTATIONS THAT INTERACT WITH ALPHA-HELIX DIPOLESmonomer1-164
98.17
REPLACEMENTS OF PRO86 IN PHAGE T4 LYSOZYME EXTEND AN ALPHA-HELIX BUT DO NOT ALTER PROTEIN STABILITYmonomer1-164
98.17
T4 Lysozyme L99A/M102H with 1,2-Azaborine boundmonomer1-164
93.9B20;SO4;BME;HED;
T4 Lysozyme L99A/M102H with toluene boundmonomer1-164
93.9BME;MBN;SO4;ACT;HED;
T4 Lysozyme L99A/M102H with 2-amino-5-chlorothiazole boundmonomer1-164
93.9BME;1DH;SO4;HED;
Contributions of all 20 amino acids at site 96 to the stability and structure of T4 lysozymemonomer1-164
98.17CL;BME;
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE…monomer1-164
96.95CL;HED;
Crystal structure of spin labeled T4 Lysozyme (V131R1)monomer1-164
96.95MTN;AZI;CL;HED;
CONTRIBUTIONS OF ENGINEERED SURFACE SALT BRIDGES TO THE STABILITY OF T4 LYSOZYME DETERMINED BY DIRE…monomer1-164
96.34
PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYMEmonomer1-164
97.56HED;
Contributions of all 20 amino acids at site 96 to the stability and structure of T4 lysozymemonomer1-164
98.17CL;BME;
T4 Lysozyme L99A with Ethylbenzene Boundmonomer1-164
98.17PYJ;EPE;
ANALYSIS OF THE INTERACTION BETWEEN CHARGED SIDE CHAINS AND THE ALPHA-HELIX DIPOLE USING DESIGNED T…monomer1-164
98.17BME;
1,3,5-trifluoro-2,4,6-trichlorobenzene binding in the hydrophobic cavity of T4 lysozyme L99A mutantmonomer1-164
96.95PO4;F3B;HED;
Structure of Spin-labeled T4 Lysozyme Mutant L118R1monomer1-164
96.95MTN;
CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT T152Smonomer1-164
96.95CL;HED;
CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT T152Vmonomer1-164
96.95CL;HED;
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE…monomer1-164
96.95CL;HED;
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE…monomer1-164
96.95CL;HED;
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE…monomer1-164
96.95CL;HED;
HYDROLASEmonomer1-164
96.95CL;BME;
BACTERIOPHAGE T4 LYSOZYMEmonomer1-164
98.17
Crystal structure of spin labeled T4 Lysozyme (V131R1B)monomer1-164
96.95R1B;AZI;CL;HED;
CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT V149Gmonomer1-164
96.95CL;HED;
CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT V149Imonomer1-164
96.95CL;HED;
Contributions of all 20 amino acids at site 96 to stability and structure of T4 lysozymemonomer1-164
98.17CL;BME;
Crystal Structure of Spin Labeled T4 Lysozyme Mutant 115-119RXmonomer1-164
96.34RXR;AZI;CL;HED;BME;
Benzene binding in the hydrophobic cavity of T4 lysozyme L99A mutantmonomer1-164
96.95PO4;CL;HED;BNZ;
Bromopentafluorobenzene binding in the hydrophobic cavity of T4 lysozyme L99A mutantmonomer1-164
96.95PO4;BBF;HED;
CUMULATIVE SITE-DIRECTED CHARGE-CHANGE REPLACEMENTS IN BACTERIOPHAGE T4 LYSOZYME SUGGEST THAT LONG-…monomer1-164
98.17
REPLACEMENTS OF PRO86 IN PHAGE T4 LYSOZYME EXTEND AN ALPHA-HELIX BUT DO NOT ALTER PROTEIN STABILITYmonomer1-164
98.17
Iodobenzene binding in the hydrophobic cavity of T4 lysozyme L99A mutantmonomer1-164
96.95PO4;PIH;HED;
REPLACEMENTS OF PRO86 IN PHAGE T4 LYSOZYME EXTEND AN ALPHA-HELIX BUT DO NOT ALTER PROTEIN STABILITYmonomer1-164
98.17
E11N Mutant of T4 Lysozymemonomer1-164
96.95CL;BME;
Chloropentafluorobenzene binding in the hydrophobic cavity of T4 lysozyme L99A mutantmonomer1-164
96.95PO4;CL;BCF;HED;
CUMULATIVE SITE-DIRECTED CHARGE-CHANGE REPLACEMENTS IN BACTERIOPHAGE T4 LYSOZYME SUGGEST THAT LONG-…monomer1-164
98.17
Xray crystal structure of lysozyme mutant L20/R63A liganded to ethylguanidiniummonomer1-164
96.34BME;EGD;
REPLACEMENTS OF PRO86 IN PHAGE T4 LYSOZYME EXTEND AN ALPHA-HELIX BUT DO NOT ALTER PROTEIN STABILITYmonomer1-164
98.17
D20E MUTANT STRUCTURE OF T4 LYSOZYMEmonomer1-164
96.95HED;
Pentafluorobenzene binding in the hydrophobic cavity of T4 lysozyme L99A mutantmonomer1-164
96.95PO4;CL;F5B;HED;
CONTRIBUTIONS OF ENGINEERED SURFACE SALT BRIDGES TO THE STABILITY OF T4 LYSOZYME DETERMINED BY DIRE…monomer1-164
98.17
T4 Lysozyme L99A with n-Pentylbenzene Boundmonomer1-164
98.173H2;EPE;
PERTURBATION OF TRP 138 IN T4 LYSOZYME BY MUTATIONS AT GLN 105 USED TO CORRELATE CHANGES IN STRUCTU…monomer1-164
98.17BME;
STRUCTURAL AND THERMODYNAMIC ANALYSIS OF THE PACKING OF TWO ALPHA-HELICES IN BACTERIOPHAGE T4 LYSOZ…monomer1-164
97.56
Bacteriophage T4 lysozyme mutant D89A in wildtype background at room temperaturemonomer1-164
98.17CL;BME;
CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT T152Cmonomer1-164
96.95CL;HED;
CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT V149Smonomer1-164
96.95CL;HED;
Mutant K85A of T4 lysozyme in wildtype background at room temperaturemonomer1-164
98.17CL;BME;
STRUCTURAL AND THERMODYNAMIC ANALYSIS OF THE PACKING OF TWO ALPHA-HELICES IN BACTERIOPHAGE T4 LYSOZ…monomer1-164
98.17BME;
CONTRIBUTIONS OF ENGINEERED SURFACE SALT BRIDGES TO THE STABILITY OF T4 LYSOZYME DETERMINED BY DIRE…monomer1-164
98.17
CONTRIBUTIONS OF LEFT-HANDED HELICAL RESIDUES TO THE STRUCTURE AND STABILITY OF BACTERIOPHAGE T4 LY…monomer1-164
98.17
ENHANCED PROTEIN THERMOSTABILITY FROM DESIGNED MUTATIONS THAT INTERACT WITH ALPHA-HELIX DIPOLESmonomer1-164
98.17
CONTRIBUTIONS OF ENGINEERED SURFACE SALT BRIDGES TO THE STABILITY OF T4 LYSOZYME DETERMINED BY DIRE…monomer1-164
96.95
STRUCTURAL AND THERMODYNAMIC ANALYSIS OF THE PACKING OF TWO ALPHA-HELICES IN BACTERIOPHAGE T4 LYSOZ…monomer1-164
96.95
T26D MUTANT OF T4 LYSOZYMEmonomer1-164
96.95CL;HED;
CONTRIBUTIONS OF ENGINEERED SURFACE SALT BRIDGES TO THE STABILITY OF T4 LYSOZYME DETERMINED BY DIRE…monomer1-164
96.95
T26H Mutant of T4 Lysozymemonomer1-164
96.95HED;
E11H Mutant of T4 Lysozymemonomer1-164
96.95CL;BME;
T4 LYSOZYME CORE REPACKING MUTANT A111V/CORE10/TAmonomer1-164
92.07K;CL;HED;
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYMEmonomer1-164
98.17BME;
T4 LYSOZYME MUTANT M6Lmonomer1-164
96.95CL;BME;
LYSOZYMEmonomer1-164
96.95CL;BME;
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE…monomer1-164
96.34CL;HED;
Alternative Structures of a Sequence Extended T4 Lysozyme Show that the Highly Conserved Beta-Sheet…monomer1-164
97.53BME;
T4 lysozyme circular permutantmonomer1-164
98.01CL;
HIGH-RESOLUTION STRUCTURE OF THE TEMPERATURE-SENSITIVE MUTANT OF PHAGE LYSOZYME, ARG 96 (RIGHT ARRO…monomer1-164
98.17
THE STRUCTURAL AND THERMODYNAMIC CONSEQUENCES OF BURYING A CHARGED RESIDUE WITHIN THE HYDROPHOBIC C…monomer1-164
96.95
T4 Lysozyme S44E/WT*monomer1-164
96.95BME;
STRUCTURAL AND THERMODYNAMIC ANALYSIS OF THE PACKING OF TWO ALPHA-HELICES IN BACTERIOPHAGE T4 LYSOZ…monomer1-164
96.95
PERTURBATION OF TRP 138 IN T4 LYSOZYME BY MUTATIONS AT GLN 105 USED TO CORRELATE CHANGES IN STRUCTU…monomer1-164
98.17BME;
REPLACEMENTS OF PRO86 IN PHAGE T4 LYSOZYME EXTEND AN ALPHA-HELIX BUT DO NOT ALTER PROTEIN STABILITYmonomer1-164
98.17
Mutant R96A OF T4 lysozyme in wildtype background at 298Kmonomer1-164
98.17CL;BME;
PERTURBATION OF TRP 138 IN T4 LYSOZYME BY MUTATIONS AT GLN 105 USED TO CORRELATE CHANGES IN STRUCTU…monomer1-164
98.17BME;
CRYSTAL STRUCTURE OF T4-LYSOZYME GENERATED FROM SYNTHETIC CODING DNA EXPRESSED IN ESCHERICHIA COLImonomer1-164
98.78
Repacking of the Core of T4 Lysozyme by Automated Designmonomer1-164
93.29
LYSOZYMEmonomer1-164
96.95CL;BME;
Hexafluorobenzene binding in the hydrophobic cavity of T4 lysozyme L99A mutantmonomer1-164
96.95PO4;CL;HFB;HED;
D20C MUTANT OF T4 LYSOZYMEmonomer1-164
96.95BME;
STRUCTURE OF A HINGE-BENDING BACTERIOPHAGE T4 LYSOZYME MUTANT, ILE3-> PROmonomer1-164
98.17
USE OF SEQUENCE DUPLICATION TO ENGINEER A LIGAND-TRIGGERED LONG-DISTANCE MOLECULAR SWITCH IN T4 Lys…monomer1-164
96.34CL;GAI;HED;
Structure of DCN1 bound to NAcM-HITmonomer1-164
96.958Z7;
Crystal Structure T4 Lysozyme incorporating an unnatural amino acid p-iodo-L-phenylalanine at posit…monomer1-164
98.78CL;BME;
GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONSmonomer1-164
96.34CL;HED;
Crystal structure of spin labeled T4 Lysozyme (V131R1) at 291 Kmonomer1-164
96.95MTN;AZI;CL;HED;
T26Q MUTANT OF T4 LYSOZYMEmonomer1-164
96.95CL;BME;
Crystal structure of phage T4 lysozyme mutant Y24A/Y25A/T26A/I27A/C54T/C97Amonomer1-164
95.12BME;
CONSERVATION OF SOLVENT-BINDING SITES IN 10 CRYSTAL FORMS OF T4 LYSOZYMEmonomer1-164
98.17
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYMEmonomer1-164
93.29CL;
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYMEmonomer1-164
91.46SO4;
Alternative Structures of a Sequence Extended T4 Lysozyme Show that the Highly Conserved Beta-Sheet…monomer1-164
97.56SO4;
T26E APO STRUCTURE OF T4 LYSOZYMEmonomer1-164
96.95CL;BME;
Crystal structure of phage T4 lysozyme mutant G28A/I29A/G30A/C54T/C97Amonomer1-164
95.73
ENHANCEMENT OF PROTEIN STABILITY BY THE COMBINATION OF POINT MUTATIONS IN T4 LYSOZYME IS ADDITIVEmonomer1-164
94.51
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYMEmonomer1-164
96.95BME;
CONSERVATION OF SOLVENT-BINDING SITES IN 10 CRYSTAL FORMS OF T4 LYSOZYMEmonomer1-164
98.17
Are Carboxy Terminii of Helices Coded by the Local Sequence or by Tertiary Structure Contactsmonomer1-164
96.95
Fusion protein of T4 lysozyme and B4 domain of protein A from staphylococcal aureus with chemical c…monomer1-164
97.14EYC;
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYMEmonomer1-164
95.73
Sequential reorganization of beta-sheet topology by insertion of a single strandmonomer1-164
97.56SO4;
Solution Structure of a Minor and Transiently Formed State of a T4 Lysozyme Mutantmonomer1-164
95.73
Solution Structure of a Minor and Transiently Formed State of a T4 Lysozyme Mutantmonomer1-164
96.95
Structure of spin-labeled T4 lysozyme mutant A41R1monomer1-164
96.95MTN;BME;
Crystal structure of spin labeled T4 Lysozyme (A82R1)monomer1-164
96.95MTN;AZI;CL;HED;
Structure of Spin-labeled T4 Lysozyme Mutant T115R1 at Room Temperaturemonomer1-164
96.95MTN;BME;
Neutron crystal structure of T4L L99AEmonomer1-164
96.95CL;
Neutron structure of the T26H mutant of T4 lysozymemonomer1-164
96.95NA;CL;
Structure of spin-labeled T4 lysozyme mutant S44R1monomer1-164
96.34MTN;HED;
Neutron crystal structure of wtT4LEmonomer1-164
97.56CL;
Neutron crystal structure of wtT4LDmonomer1-164
97.56CL;
Neutron crystallographic structure of perdeuterated T4 lysozyme cysteine-free pseudo-wild type at c…monomer1-164
97.56CL;
T4 lysozyme mutant L99A in complex with 1-fluoranylnaphthalenemonomer1-163
98.16Y84;BME;TRS;
T4 lysozyme mutant L99A in complex with 2-butylthiophenemonomer1-163
98.16Y8G;BME;TRS;
T4 lysozyme mutant L99A in complex with 3-fluoroiodobenzenemonomer1-163
98.16Y7V;BME;TRS;
T4 lysozyme mutant L99A in complex with 1-bromanyl-4-fluoranyl-benzenemonomer1-163
98.15BME;TRS;Y87;
New azaborine compounds bind to the T4 lysozyme L99A cavity -ethylbenzene as controlmonomer1-163
96.93HED;PO4;PYJ;
(Z)-Thiophene-2-carboxaldoxime in complex with T4 lysozyme L99A/M102Qmonomer1-163
96.32PO4;JZ5;BME;
4,5,6,7-tetrahydroindole in complex with T4 lysozyme L99A/M102Qmonomer1-163
96.32JZ9;BME;PO4;
Spin-Labeled T4 Lysozyme Construct T151V1monomer1-163
96.93CL;K;V1A;PO4;HEZ;
Spin-Labeled T4 Lysozyme Construct A73V1monomer1-163
96.93CL;K;V1A;HEZ;
AN ADAPTABLE METAL-BINDING SITE ENGINEERED INTO T4 LYSOZYMEmonomer1-163
96.32CL;ZN;
STRUCTURE OF A THERMOSTABLE DISULFIDE-BRIDGE MUTANT OF PHAGE T4 LYSOZYME SHOWS THAT AN ENGINEERED C…monomer1-163
96.93
2-propylphenol in complex with T4 lysozyme L99A/M102Qmonomer1-163
96.32PO4;JZ4;BME;
A COVALENT ENZYME-SUBSTRATE INTERMEDIATE WITH SACCHARIDE DISTORTION IN A MUTANT T4 LYSOZYMEmonomer1-163
96.93MUB;BME;
Crystal structure of the phosphatidylinositol 4-kinase IIbetamonomer2-164
97.55ATP;
CONSERVATION OF SOLVENT-BINDING SITES IN 10 CRYSTAL FORMS OF T4 LYSOZYMEmonomer1-163
95.71SO4;
Structure of the T4Lnano fusion proteinmonomer2-164
98.77CA;GOL;CL;
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYMEmonomer1-163
96.93
Crystal structure of phosphatidyl inositol 4-kinase II beta in complex with MM1373monomer2-164
97.55L6A;
Crystal structure of a pesticin (translocation and receptor binding domain) from Y. pestis and T4-l…monomer2-164
97.55SO4;
Crystal structure of phosphatidyl inositol 4-kinase II alpha in the apo statemonomer2-164
97.55
T4 lysozyme mutant L99A in complex with 1-fluoranyl-4-iodanyl-benzenemonomer1-162
98.15Y8D;BME;TRS;
T4 lysozyme mutant L99Amonomer1-162
98.14YGV;TRS;
T4 lysozyme mutant L99Amonomer1-162
98.15YGG;TRS;
T4 lysozyme mutant L99Amonomer1-162
98.15YGJ;TRS;
Evaulaution at Atomic Resolution of the Role of Strain in Destabilizing the Temperature Sensitive T…monomer1-162
98.77HED;BME;PO4;CL;K;
T4 lysozyme mutant L99A in complex with 1-fluoro-2-[(prop-2-en-1-yl)oxy]benzenemonomer1-162
98.15ZNV;BME;TRS;
T4 Lysozyme L99A - benzylacetate - cryomonomer1-162
98.15TRS;BME;CL;J0Z;
T4 Lysozyme L99A - toluene - cryomonomer1-162
98.15MBN;
T4 Lysozyme L99A - 3-iodotoluene - cryomonomer1-162
98.15TRS;BME;CL;XQJ;
Evaulaution at Atomic Resolution of the Role of Strain in Destabilizing the Temperature Sensitive T…monomer1-162
98.15PO4;NA;CL;K;
T4 lysozyme mutant L99Amonomer1-162
98.12YGM;TRS;
2-ethoxy-3,4-dihydro-2h-pyran in complex with T4 lysozyme L99A/M102Qmonomer1-162
96.3PO4;BME;JZ7;
T4 Lysozyme L99A - iodobenzene - RTmonomer1-162
98.15TRS;BME;CL;PIH;
Benzylacetate in complex with T4 lysozyme L99A/M102Qmonomer1-162
96.3PO4;J0Z;BME;
N-phenylglycinonitrile in complex with T4 lysozyme L99A/M102Qmonomer1-162
97.53PO4;264;
2-nitrothiophene in complex with T4 lysozyme L99A/M102Qmonomer1-162
97.53PO4;265;
T4 Lysozyme L99A - o-xylene - RTmonomer1-162
98.15TRS;CL;BME;OXE;
T4 Lysozyme L99A - Apo - cryomonomer1-162
98.15TRS;BME;CL;
T4 Lysozyme L99A - 3-iodotoluene - RTmonomer1-162
98.15TRS;BME;CL;XQJ;
T4 lysozyme Y18Ymbrmonomer1-162
96.91HED;
T4 Lysozyme L99A - toluene - RTmonomer1-162
98.15TRS;CL;MBN;BME;
T4 lysozyme Y18Ymclmonomer1-162
96.91HED;NA;
T4 Lysozyme L99A - ethylbenzene - RTmonomer1-162
98.15TRS;BME;CL;PYJ;
2-phenoxyethanol in complex with T4 lysozyme L99A/M102Qmonomer1-162
97.53PO4;268;
T4 Lysozyme L99A - Apo - RTmonomer1-162
98.15TRS;CL;BME;
T4 lysozyme M102E/L99A mutant with buried charge in apolar cavity--Apo structuremonomer1-162
93.83BME;CO3;TAM;SO4;
Thieno[3,2-b]thiophene in complex with T4 lysozyme L99A/M102Qmonomer1-162
96.3PO4;J1Z;BME;
T4 Lysozyme L99A - propylbenzene - RTmonomer1-162
98.15TRS;CL;3H0;
PSEUDO T4 LYSOZYME MUTANT - Y18Fmonomer1-162
96.91HED;
Nitrosobenzene in complex with T4 lysozyme L99A/M102Qmonomer1-162
96.3PO4;NBE;
3-methylbenzylazide in complex with T4 lysozyme L99Amonomer1-162
96.91PO4;263;
2-(n-propylthio)ethanol in complex with T4 lysozyme L99A/M102Qmonomer1-162
97.53PO4;266;
T4 Lysozyme L99A - 4-iodotoluene - RTmonomer1-162
98.15TRS;CL;XQM;
T4 Lysozyme L99A - benzylacetate - RTmonomer1-162
98.15TRS;BME;CL;J0Z;
PSEUDO T4 LYSOZYMEmonomer1-162
97.53HED;
PSEUDO T4 LYSOZYME MUTANT - Y88Fmonomer1-162
96.91HED;
T4 lysozyme mutant L99A in complex with 4-(3-phenylpropyl)anilinemonomer1-162
98.15EPE;Y8M;
PSEUDO T4 LYSOZYME MUTANT - Y88PHE-Imonomer1-162
96.91HED;NA;
T4 lysozyme M102E/L99A mutant with buried charge in apolar cavity--aniline bindingmonomer1-162
93.83ANL;CA;CL;
T4 lysozyme M102E/L99A mutant with buried charge in apolar cavity--pyridine bindingmonomer1-162
93.830PY;CO3;MG;CL;
Crystal Structure of Spin Labeled T4 Lysozyme Mutant K65V1/R76V1monomer1-162
96.3V1A;HEZ;CL;K;
PSEUDO T4 LYSOZYME MUTANT - Y18PHE-METHYLmonomer1-162
96.91HED;
Catechol in complex with T4 lysozyme L99A/M102Qmonomer1-162
97.53PO4;CAQ;BME;
PSEUDO T4 LYSOZYME MUTANT - Y88PHE-BRmonomer1-162
97.53HED;
(r)(+)-3-chloro-1-phenyl-1-propanol in complex with T4 lysozyme L99A/M102Qmonomer1-162
97.53PO4;269;
PSEUDO T4 LYSOZYME MUTANT - Y88PHE-METHYLmonomer1-162
96.91HED;PO4;
2-methylphenol in complex with T4 lysozyme L99A/M102Qmonomer1-162
96.3PO4;JZ0;
5-chloro-2-methylphenol in complex with T4 lysozyme L99A/M102Qmonomer1-162
96.3PO4;JZ2;
T4 lysozyme M102E/L99A mutant with buried charge in apolar cavity--Benzene bindingmonomer1-162
93.83BNZ;BME;CO3;EPE;SO4;
PSEUDO T4 LYSOZYME MUTANT - Y18PHE-Imonomer1-162
96.91HED;
3-methylbenzylazide in complex with T4 L99A/M102Qmonomer1-162
97.53PO4;263;
4-(methylthio)nitrobenzene in complex with T4 lysozyme L99Amonomer1-162
96.91PO4;259;
T4 lysozyme Y18Ymimonomer1-162
97.53HED;
THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A…monomer1-162
96.91CL;BME;
Multiple Methionine Substitutions in T4 Lysozymemonomer1-162
90.74PO4;CL;BME;
PSEUDO T4 LYSOZYME MUTANT - Y18PHE-BRmonomer1-162
97.53HED;
TOWARD A SIMPLIFICATION OF THE PROTEIN FOLDING PROBLEM: A STABILIZING POLYALANINE ALPHA-HELIX ENGIN…monomer1-162
96.91CL;BME;
TOLERANCE OF T4 LYSOZYME TO MULTIPLE XAA (RIGHT ARROW) ALA SUBSTITUTIONS: A POLYALANINE ALPHA-HELIX…monomer1-162
96.91CL;BME;
Multiple Methionine Substitutions are Tolerated in T4 Lysozyme and have Coupled Effects on Folding …monomer1-162
92.59PO4;CL;K;HED;
DISSECTION OF HELIX CAPPING IN T4 LYSOZYME BY STRUCTURAL AND THERMODYNAMIC ANALYSIS OF SIX AMINO AC…monomer1-162
96.91CL;BME;
Stabilizing Disulfide Bridge Mutant of T4 Lysozymemonomer1-162
96.3CL;BME;
STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYMEmonomer1-162
96.91CL;BME;
STRUCTURES OF RANDOMLY GENERATED MUTANTS OF T4 LYSOZYME SHOW THAT PROTEIN STABILITY CAN BE ENHANCED…monomer1-162
96.91CL;BME;
STRUCTURES OF RANDOMLY GENERATED MUTANTS OF T4 LYSOZYME SHOW THAT PROTEIN STABILITY CAN BE ENHANCED…monomer1-162
96.91CL;BME;
CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BONDmonomer1-162
96.91CL;BME;
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYMEmonomer1-162
96.3BME;
PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYMEmonomer1-162
97.53HED;
THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A…monomer1-162
96.91CL;BME;
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE…monomer1-162
96.91CL;HED;
THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A…monomer1-162
96.91CL;BME;
RAPID CRYSTALLIZATION OF T4 LYSOZYME BY INTERMOLECULAR DISULFIDE CROSSLINKINGmonomer1-162
96.91CL;BME;
STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYMEmonomer1-162
96.91CL;BME;
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE…monomer1-162
96.91CL;BME;HED;
STRUCTURES OF RANDOMLY GENERATED MUTANTS OF T4 LYSOZYME SHOW THAT PROTEIN STABILITY CAN BE ENHANCED…monomer1-162
96.91CL;BME;
RAPID CRYSTALLIZATION OF T4 LYSOZYME BY INTERMOLECULAR DISULFIDE CROSSLINKINGmonomer1-162
96.3CL;BME;
CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT T152Imonomer1-162
96.91CL;HED;
COMPARISON OF THE CRYSTAL STRUCTURE OF BACTERIOPHAGE T4 LYSOZYME AT LOW, MEDIUM, AND HIGH IONIC STR…monomer1-162
98.77CL;BME;
CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT V149Cmonomer1-162
96.91CL;HED;
2-ethoxyphenol in complex with T4 lysozyme L99Amonomer1-162
96.91PO4;261;
A CAVITY-CONTAINING MUTANT OF T4 LYSOZYME IS STABILIZED BY BURIED BENZENEmonomer1-162
96.91CL;BME;BNZ;
ANALYSIS OF THE INTERACTION BETWEEN CHARGED SIDE CHAINS AND THE ALPHA-HELIX DIPOLE USING DESIGNED T…monomer1-162
96.91CL;BME;
SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFEREN…monomer1-162
96.91CL;BME;
2-ethylphenol in complex with T4 lysozyme L99A/M102Qmonomer1-162
96.3PO4;JZ1;BME;
MULTIPLE STABILIZING ALANINE REPLACEMENTS WITHIN ALPHA-HELIX 126-134 OF T4 LYSOZYME HAVE INDEPENDEN…monomer1-162
96.3CL;BME;
TOLERANCE OF T4 LYSOZYME TO MULTIPLE XAA (RIGHT ARROW) ALA SUBSTITUTIONS: A POLYALANINE ALPHA-HELIX…monomer1-162
96.91CL;BME;
TOLERANCE OF T4 LYSOZYME TO MULTIPLE XAA (RIGHT ARROW) ALA SUBSTITUTIONS: A POLYALANINE ALPHA-HELIX…monomer1-162
96.91CL;BME;
Iodopentafluorobenzene binding in the hydrophobic cavity of T4 lysozyme L99A mutant (seleno version)monomer1-162
96.91PO4;CL;HED;BME;IBF;
Iodobenzene binding in the hydrophobic cavity of T4 lysozyme L99A mutant (seleno version)monomer1-162
96.91PO4;CL;HED;BME;PIH;
T4 LYSOZYME MUTANT M120Kmonomer1-162
96.91CL;BME;
HOW AMINO-ACID INSERTIONS ARE ALLOWED IN AN ALPHA-HELIX OF T4 LYSOZYMEmonomer1-162
97.53CL;BME;
L99G MUTANT OF T4 LYSOZYMEmonomer1-162
96.91CL;HEZ;
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYMEmonomer1-162
96.91
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE…monomer1-162
96.91CL;HED;
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE…monomer1-162
96.91CL;HED;
CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BONDmonomer1-162
96.91CL;BME;
CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BONDmonomer1-162
96.91CL;BME;
PHAGE T4 LYSOZYMEmonomer1-162
96.91CL;BME;
SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFEREN…monomer1-162
96.91CL;BME;
ANALYSIS OF THE INTERACTION BETWEEN CHARGED SIDE CHAINS AND THE ALPHA-HELIX DIPOLE USING DESIGNED T…monomer1-162
97.53CL;BME;
METHIONINE CORE MUTANT OF T4 LYSOZYMEmonomer1-162
95.68CL;HED;
ANALYSIS OF THE INTERACTION BETWEEN CHARGED SIDE CHAINS AND THE ALPHA-HELIX DIPOLE USING DESIGNED T…monomer1-162
96.91CL;BME;
DETERMINATION OF ALPHA-HELIX PROPENSITY WITHIN THE CONTEXT OF A FOLDED PROTEIN: SITES 44 AND 131 IN…monomer1-162
98.15CL;BME;
beta-chlorophenetole in complex with T4 lysozyme L99Amonomer1-162
96.91PO4;258;
SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFEREN…monomer1-162
96.91CL;BME;
Duplication-extension of Helix A of T4 lysozymemonomer1-162
97.53
2-ethoxyphenol in complex with T4 lysozyme L99A/M102Qmonomer1-162
96.3PO4;261;
DETERMINATION OF ALPHA-HELIX PROPENSITY WITHIN THE CONTEXT OF A FOLDED PROTEIN: SITES 44 AND 131 IN…monomer1-162
98.15CL;BME;
DISSECTION OF HELIX CAPPING IN T4 LYSOZYME BY STRUCTURAL AND THERMODYNAMIC ANALYSIS OF SIX AMINO AC…monomer1-162
96.91CL;BME;
DISSECTION OF HELIX CAPPING IN T4 LYSOZYME BY STRUCTURAL AND THERMODYNAMIC ANALYSIS OF SIX AMINO AC…monomer1-162
96.91CL;BME;
Crystal structure of phage T4 lysozyme mutant L32A/L33A/T34A/C54T/C97A/E108Vmonomer1-162
95.57PO4;CL;BME;
DISSECTION OF HELIX CAPPING IN T4 LYSOZYME BY STRUCTURAL AND THERMODYNAMIC ANALYSIS OF SIX AMINO AC…monomer1-162
96.91CL;BME;
ARE CARBOXY TERMINII OF HELICES CODED BY THE LOCAL SEQUENCE OR BY TERTIARY STRUCTURE CONTACTSmonomer1-162
96.91CL;BME;
DISSECTION OF HELIX CAPPING IN T4 LYSOZYME BY STRUCTURAL AND THERMODYNAMIC ANALYSIS OF SIX AMINO AC…monomer1-162
96.91CL;BME;
T4 LYSOZYME MUTANT L118Amonomer1-162
96.91CL;HED;
STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYMEmonomer1-162
96.91CL;
STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYMEmonomer1-162
96.91CL;BME;
STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYMEmonomer1-162
96.91CL;BME;
THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A…monomer1-162
96.91CL;BME;
THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A…monomer1-162
96.91CL;BME;
THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A…monomer1-162
96.91CL;BME;
CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BONDmonomer1-162
96.91CL;BME;
CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BONDmonomer1-162
96.91CL;BME;
CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BONDmonomer1-162
96.91CL;BME;
SPECIFICITY OF LIGAND BINDING IN A BURIED NON-POLAR CAVITY OF T4 LYSOZYME: LINKAGE OF DYNAMICS AND …monomer1-162
96.91CL;HED;BNZ;
SPECIFICITY OF LIGAND BINDING IN A BURIED NON-POLAR CAVITY OF T4 LYSOZYME: LINKAGE OF DYNAMICS AND …monomer1-162
96.91CL;HED;BZF;
SPECIFICITY OF LIGAND BINDING IN A BURIED NON-POLAR CAVITY OF T4 LYSOZYME: LINKAGE OF DYNAMICS AND …monomer1-162
96.91CL;HED;DEN;
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE…monomer1-162
96.3CL;HED;
AN ADAPTABLE METAL-BINDING SITE ENGINEERED INTO T4 LYSOZYMEmonomer1-162
96.3CL;NI;
STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYMEmonomer1-162
96.91CL;BME;
STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYMEmonomer1-162
96.91CL;BME;
STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYMEmonomer1-162
96.91CL;BME;
STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYMEmonomer1-162
96.91CL;BME;
THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A…monomer1-162
96.91CL;BME;
THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A…monomer1-162
96.91CL;BME;
CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BONDmonomer1-162
96.3CL;BME;
CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BONDmonomer1-162
96.3CL;BME;
CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BONDmonomer1-162
96.91CL;BME;
SPECIFICITY OF LIGAND BINDING IN A BURIED NON-POLAR CAVITY OF T4 LYSOZYME: LINKAGE OF DYNAMICS AND …monomer1-162
96.91CL;HED;I4B;
SPECIFICITY OF LIGAND BINDING IN A BURIED NON-POLAR CAVITY OF T4 LYSOZYME: LINKAGE OF DYNAMICS AND …monomer1-162
96.91CL;HED;IND;
SPECIFICITY OF LIGAND BINDING IN A BURIED NON-POLAR CAVITY OF T4 LYSOZYME: LINKAGE OF DYNAMICS AND …monomer1-162
96.91CL;HED;N4B;
SPECIFICITY OF LIGAND BINDING IN A BURIED NON-POLAR CAVITY OF T4 LYSOZYME: LINKAGE OF DYNAMICS AND …monomer1-162
96.91CL;HED;PXY;
SPECIFICITY OF LIGAND BINDING IN A BURIED NON-POLAR CAVITY OF T4 LYSOZYME: LINKAGE OF DYNAMICS AND …monomer1-162
96.91CL;HED;OXE;
GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONSmonomer1-162
98.15CL;BME;
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE…monomer1-162
96.91CL;HED;
CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BONDmonomer1-162
96.3CL;BME;
GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONSmonomer1-162
96.91CL;GAI;BME;
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE…monomer1-162
96.91CL;
COMPARISON OF THE CRYSTAL STRUCTURE OF BACTERIOPHAGE T4 LYSOZYME AT LOW, MEDIUM, AND HIGH IONIC STR…monomer1-162
98.77CL;BME;
COMPARISON OF THE CRYSTAL STRUCTURE OF BACTERIOPHAGE T4 LYSOZYME AT LOW, MEDIUM, AND HIGH IONIC STR…monomer1-162
98.77CL;BME;
COMPARISON OF THE CRYSTAL STRUCTURE OF BACTERIOPHAGE T4 LYSOZYME AT LOW, MEDIUM, AND HIGH IONIC STR…monomer1-162
98.77CL;
T4 LYSOZYME MUTANT C54T/C97A/Q105Mmonomer1-162
96.91CL;BME;
Crystal structure of spin labeled T4 Lysozyme (T151R1) at 100 Kmonomer1-162
96.91MTN;HED;AZI;CL;
DESIGN AND STRUCTURAL ANALYSIS OF ALTERNATIVE HYDROPHOBIC CORE PACKING ARRANGEMENTS IN BACTERIOPHAG…monomer1-162
95.68CL;BME;
SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFEREN…monomer1-162
96.91CL;BME;
Iodopentafluorobenzene binding in the hydrophobic cavity of T4 lysozyme L99A mutantmonomer1-162
96.91PO4;IBF;HED;
ANALYSIS OF THE INTERACTION BETWEEN CHARGED SIDE CHAINS AND THE ALPHA-HELIX DIPOLE USING DESIGNED T…monomer1-162
96.91CL;BME;
SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFEREN…monomer1-162
96.91CL;BME;
SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFEREN…monomer1-162
96.91CL;BME;
SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFEREN…monomer1-162
96.91CL;BME;
T4 LYSOZYME MUTANT L121Mmonomer1-162
96.91CL;HED;
T4 LYSOZYME MUTANT C54T/C97A/L133A IN THE PRESENCE OF 8 ATM ARGONmonomer1-162
98.15CL;BME;
T4 lysozyme with C-terminal extensionmonomer1-162
96.91PO4;CL;GOL;
Specificity of ligand binding in a buried non-polar cavity of t4 lysozyme: linkage of dynamics and …monomer1-162
96.91CL;HED;PYJ;
THE INTRODUCTION OF STRAIN AND ITS EFFECTS ON THE STRUCTURE AND STABILITY OF T4 LYSOZYMEmonomer1-162
96.91CL;HED;
1,2-dichlorobenzene in complex with T4 Lysozyme L99Amonomer1-162
96.91PO4;BME;YAN;
2,6-difluorobenzylbromide complex with T4 lysozyme L99Amonomer1-162
96.91PO4;260;
4-chloro-1h-pyrazole in complex with T4 lysozyme L99A/M102Qmonomer1-162
96.3PO4;JZ6;BME;
L99G/E108V MUTANT OF T4 LYSOZYMEmonomer1-162
96.3CL;HEZ;
T4 lysozyme M102E/L99A mutant with buried charge in apolar cavity--Toluene bindingmonomer1-162
93.83MBN;CA;CL;
GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONSmonomer1-162
96.91CL;BME;BNZ;
THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A…monomer1-162
96.91CL;BME;
THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A…monomer1-162
96.91CL;BME;
STRUCTURAL BASIS OF AMINO ACID ALPHA HELIX PROPENSITYmonomer1-162
96.91
ROLE OF BACKBONE FLEXIBILITY IN THE ACCOMMODATION OF VARIANTS THAT REPACK THE CORE OF T4 LYSOZYMEmonomer1-162
94.44CL;BME;
CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BONDmonomer1-162
96.3CL;BME;
CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BONDmonomer1-162
93.21CL;BME;
THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A…monomer1-162
96.91CL;BME;
STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYMEmonomer1-162
96.91CL;BME;
THERMODYNAMIC AND STRUCTURAL COMPENSATION IN "SIZE-SWITCH" CORE-REPACKING VARIANTS OF T4 LYSOZYMEmonomer1-162
96.3CL;BME;
T4 Lysozyme Mutant L99A/M102Q Bound by 2-fluoroanilinemonomer1-162
97.53CL;BME;1AN;
T4 LYSOZYME MUTANT, T21H/C54T/C97A/Q141H/T142Hmonomer1-162
95.68SO4;CL;CO;
MULTIPLE STABILIZING ALANINE REPLACEMENTS WITHIN ALPHA-HELIX 126-134 OF T4 LYSOZYME HAVE INDEPENDEN…monomer1-162
97.53CL;BME;
T4 lysozyme mutant L99A/M102Q bound by 3-chlorophenolmonomer1-162
97.53CL;BME;3CH;
MULTIPLE STABILIZING ALANINE REPLACEMENTS WITHIN ALPHA-HELIX 126-134 OF T4 LYSOZYME HAVE INDEPENDEN…monomer1-162
97.53CL;BME;
T4 LYSOZYME MUTANT L84Mmonomer1-162
96.91CL;HED;
SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFEREN…monomer1-162
96.91CL;BME;
THE INTRODUCTION OF STRAIN AND ITS EFFECTS ON THE STRUCTURE AND STABILITY OF T4 LYSOZYMEmonomer1-162
96.91
Bacteriophage T4 lysozyme mutant R96V in wildtype background at low temperaturemonomer1-162
98.15HEZ;MPD;
T4 LYSOZYME MUTANT L133Mmonomer1-162
96.91CL;HED;
PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYMEmonomer1-162
97.26HED;
PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYMEmonomer1-162
97.53
METHIONINE CORE MUTANT OF T4 LYSOZYMEmonomer1-162
96.91CL;HED;
N-TERMINAL DOMAIN CORE METHIONINE MUTATIONmonomer1-162
96.91CL;HED;
METHIONINE CORE MUTANT OF T4 LYSOZYMEmonomer1-162
95.06CL;HED;
TOLERANCE OF T4 LYSOZYME TO PROLINE SUBSTITUTIONS WITHIN THE LONG INTERDOMAIN ALPHA-HELIX ILLUSTRAT…monomer1-162
96.91CL;BME;
T4 LYSOZYME MUTANT V149Mmonomer1-162
96.91CL;HED;
T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 2 ATM XENONmonomer1-162
96.91CL;XE;BME;
DETERMINATION OF ALPHA-HELIX PROPENSITY WITHIN THE CONTEXT OF A FOLDED PROTEIN: SITES 44 AND 131 IN…monomer1-162
98.15CL;BME;
CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT T152Amonomer1-162
96.91CL;HED;
T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 4 ATM KRYPTONmonomer1-162
96.91CL;KR;BME;
E108V MUTANT OF T4 LYSOZYMEmonomer1-162
96.91CL;HED;
T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 4 ATM XENONmonomer1-162
96.91CL;XE;BME;
THE INTRODUCTION OF STRAIN AND ITS EFFECTS ON THE STRUCTURE AND STABILITY OF T4 LYSOZYMEmonomer1-162
96.91
T4 LYSOZYME MUTANT WITH CYS 54 REPLACED BY THR, CYS 97 REPLACED BY ALA, THR 21 REPLACED BY CYS AND …monomer1-162
96.3HED;
T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 8 ATM ARGONmonomer1-162
96.91CL;AR;BME;
T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 8 ATM KRYPTONmonomer1-162
96.91CL;KR;BME;
T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 8 ATM XENONmonomer1-162
96.91CL;XE;BME;
HOW AMINO-ACID INSERTIONS ARE ALLOWED IN AN ALPHA-HELIX OF T4 LYSOZYMEmonomer1-162
97.44CL;BME;
A HELIX INITIATION SIGNAL IN T4 LYSOZYME IDENTIFIED BY POLYALANINE MUTAGENESISmonomer1-162
91.97CL;HED;
GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONSmonomer1-162
96.91CL;BME;
GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONSmonomer1-162
98.15CL;BME;BNZ;
T4 LYSOZYME MUTANT M120Lmonomer1-162
96.91CL;BME;
THERMODYNAMIC AND STRUCTURAL COMPENSATION IN "SIZE-SWITCH" CORE-REPACKING VARIANTS OF T4 LYSOZYMEmonomer1-162
96.91CL;BME;
T4 LYSOZYME MUTANT C54T/C97A/L99A/F153A IN THE PRESENCE OF 8 ATM ARGONmonomer1-162
96.3CL;BME;
GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONSmonomer1-162
98.15PXY;BME;
GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONSmonomer1-162
96.91CL;BME;
T4 LYSOZYME MUTANT M106Lmonomer1-162
96.91CL;BME;
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE…monomer1-162
96.91CL;HED;
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE…monomer1-162
96.91CL;HED;
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE…monomer1-162
96.3CL;HED;
AN ADAPTABLE METAL-BINDING SITE ENGINEERED INTO T4 LYSOZYMEmonomer1-162
96.3CL;HED;
L99A/E108V MUTANT OF T4 LYSOZYMEmonomer1-162
96.3CL;HED;
T4 LYSOZYME MUTANT C54T/C97A IN THE PRESENCE OF 8 ATM ARGONmonomer1-162
97.53CL;BME;
T4 LYSOZYME MUTANT C54T/C97A IN THE PRESENCE OF 8 ATM KRYPTONmonomer1-162
97.53CL;KR;BME;
CAVITY CREATING MUTATIONmonomer1-162
96.91CL;HED;
T4 LYSOZYME MUTANT C54T/C97A/N101Amonomer1-162
96.91CL;HED;
T4 Lysozyme Mutant L99A/M102Qmonomer1-162
97.53CL;BME;
T4 LYSOZYME MUTANT C54T/C97A/I58Tmonomer1-162
96.91CL;BME;
T4 Lysozyme Mutant L99A/M102Q Bound by 3,5-difluoroanilinemonomer1-162
97.53CL;BME;5AN;
T4 Lysozyme Cavity Mutant L99A/M102Q Bound With 2-Propyl-Anilinemonomer1-162
97.53CL;BME;PRY;
T4 Lysozyme Cavity Mutant L99A/M102Q Bound With 4-FluoroPhenEthyl Alcoholmonomer1-162
97.53CL;BME;4FA;
MULTIPLE STABILIZING ALANINE REPLACEMENTS WITHIN ALPHA-HELIX 126-134 OF T4 LYSOZYME HAVE INDEPENDEN…monomer1-162
97.53CL;BME;
T4 LYSOZYME MUTANT L118Mmonomer1-162
96.91CL;HED;
ANALYSIS OF THE INTERACTION BETWEEN CHARGED SIDE CHAINS AND THE ALPHA-HELIX DIPOLE USING DESIGNED T…monomer1-162
98.15CL;BME;
TOLERANCE OF T4 LYSOZYME TO MULTIPLE XAA (RIGHT ARROW) ALA SUBSTITUTIONS: A POLYALANINE ALPHA-HELIX…monomer1-162
96.91CL;BME;
TOLERANCE OF T4 LYSOZYME TO MULTIPLE XAA (RIGHT ARROW) ALA SUBSTITUTIONS: A POLYALANINE ALPHA-HELIX…monomer1-162
93.21CL;BME;
A CAVITY-CONTAINING MUTANT OF T4 LYSOZYME IS STABILIZED BY BURIED BENZENEmonomer1-162
96.3CL;BME;BNZ;
ANALYSIS OF THE INTERACTION BETWEEN CHARGED SIDE CHAINS AND THE ALPHA-HELIX DIPOLE USING DESIGNED T…monomer1-162
96.91CL;BME;
MULTIPLE STABILIZING ALANINE REPLACEMENTS WITHIN ALPHA-HELIX 126-134 OF T4 LYSOZYME HAVE INDEPENDEN…monomer1-162
95.68CL;BME;
MULTIPLE STABILIZING ALANINE REPLACEMENTS WITHIN ALPHA-HELIX 126-134 OF T4 LYSOZYME HAVE INDEPENDEN…monomer1-162
98.15CL;BME;
DESIGN AND STRUCTURAL ANALYSIS OF ALTERNATIVE HYDROPHOBIC CORE PACKING ARRANGEMENTS IN BACTERIOPHAG…monomer1-162
96.3CL;BME;
SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFEREN…monomer1-162
96.3CL;BME;
DETERMINATION OF ALPHA-HELIX PROPENSITY WITHIN THE CONTEXT OF A FOLDED PROTEIN: SITES 44 AND 131 IN…monomer1-162
98.15CL;BME;
THE INTRODUCTION OF STRAIN AND ITS EFFECTS ON THE STRUCTURE AND STABILITY OF T4 LYSOZYMEmonomer1-162
96.91HED;
BACTERIOPHAGE T4 LYSOZYME MUTANTmonomer1-162
98.15BME;
AN ADAPTABLE METAL-BINDING SITE ENGINEERED INTO T4 LYSOZYMEmonomer1-162
96.3CL;CO;
1-methylpyrrole in complex with T4 Lysozyme L99Amonomer1-162
96.91PO4;MR3;
T4 LYSOZYME METHIONINE CORE MUTANTmonomer1-162
93.21CL;HED;
T4 Lysozyme Cavity Mutant L99A/M102Q Bound With 2-Chloro-6-Methyl-Anilinemonomer1-162
97.53CL;BME;2CM;
A HELIX INITIATION SIGNAL IN T4 LYSOZYME IDENTIFIED BY POLYALANINE MUTAGENESISmonomer1-162
95.06CL;HED;
THERMODYNAMIC AND STRUCTURAL COMPENSATION IN "SIZE-SWITCH" CORE-REPACKING VARIANTS OF T4 LYSOZYMEmonomer1-162
96.91CL;BME;
PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYMEmonomer1-162
97.53HED;
N-TERMINAL DOMAIN CORE METHIONINE MUTATIONmonomer1-162
96.91CL;HED;
METHIONINE CORE MUTANT OF T4 LYSOZYMEmonomer1-162
95.06CL;HED;
METHIONINE CORE MUTANT OF T4 LYSOZYMEmonomer1-162
93.83CL;HED;
T4 Lysozyme mutant R96Y at room temperaturemonomer1-162
98.15CL;BME;
T4 lysozyme mutant L99A/M102Q bound by 5-methylpyrrolemonomer1-162
97.53CL;5MP;BME;
T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 16 ATM KRYPTONmonomer1-162
96.91CL;KR;BME;
T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 32 ATM ARGONmonomer1-162
96.91CL;AR;BME;
DISSECTION OF HELIX CAPPING IN T4 LYSOZYME BY STRUCTURAL AND THERMODYNAMIC ANALYSIS OF SIX AMINO AC…monomer1-162
96.91CL;BME;
T4 Lysozyme Cavity Mutant L99A/M102Q Bound with 3-Fluoro-2-Methyl_Anilinemonomer1-162
97.53CL;BME;FLM;
ROLE OF BACKBONE FLEXIBILITY IN THE ACCOMMODATION OF VARIANTS THAT REPACK THE CORE OF T4 LYSOZYMEmonomer1-162
95.68CL;BME;
ROLE OF BACKBONE FLEXIBILITY IN THE ACCOMMODATION OF VARIANTS THAT REPACK THE CORE OF T4 LYSOZYMEmonomer1-162
95.06CL;BME;
ROLE OF BACKBONE FLEXIBILITY IN THE ACCOMMODATION OF VARIANTS THAT REPACK THE CORE OF T4 LYSOZYMEmonomer1-162
95.06CL;BME;
A HELIX INITIATION SIGNAL IN T4 LYSOZYME IDENTIFIED BY POLYALANINE MUTAGENESISmonomer1-162
96.91CL;BME;
HOW AMINO-ACID INSERTIONS ARE ALLOWED IN AN ALPHA-HELIX OF T4 LYSOZYMEmonomer1-162
97.53
ROLE OF BACKBONE FLEXIBILITY IN THE ACCOMMODATION OF VARIANTS THAT REPACK THE CORE OF T4 LYSOZYMEmonomer1-162
95.68BME;
ROLE OF BACKBONE FLEXIBILITY IN THE ACCOMMODATION OF VARIANTS THAT REPACK THE CORE OF T4 LYSOZYMEmonomer1-162
95.68CL;BME;
THERMODYNAMIC AND STRUCTURAL COMPENSATION IN "SIZE-SWITCH" CORE-REPACKING VARIANTS OF T4 LYSOZYMEmonomer1-162
96.3CL;BME;
GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONSmonomer1-162
96.91CL;BME;BNZ;
METHIONINE CORE MUTATIONmonomer1-162
94.44CL;HED;
T4 LYSOZYME MUTANT C54T/C97A IN THE PRESENCE OF 8 ATM XENONmonomer1-162
97.53CL;XE;BME;
T4 LYSOZYME MUTANT C54T/C97A/F153A IN THE PRESENCE OF 8 ATM ARGONmonomer1-162
96.91CL;BME;
SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFEREN…monomer1-162
96.91CL;BME;
T4 LYSOZYME MUTANT C54T/C97A/F153A IN THE PRESENCE OF 8 ATM KRYPTONmonomer1-162
96.91CL;KR;BME;
DESIGN AND STRUCTURAL ANALYSIS OF ALTERNATIVE HYDROPHOBIC CORE PACKING ARRANGEMENTS IN BACTERIOPHAG…monomer1-162
95.68CL;BME;
T4 LYSOZYME MUTANT C54T/C97A/L121A IN THE PRESENCE OF 8 ATM ARGONmonomer1-162
96.91CL;BME;
STRUCTURE OF A HINGE-BENDING BACTERIOPHAGE T4 LYSOZYME MUTANT, ILE3-> PROmonomer1-162
98.15CL;BME;
T4 Lysozyme Cavity Mutant L99A/M102Q Bound with 2-Allyl-6-Methyl-Phenolmonomer1-162
97.53CL;LYL;BME;
T4 LYSOZYME MUTANT C54T/C97A/L121A IN THE PRESENCE OF 8 ATM KRYPTONmonomer1-162
96.91CL;KR;BME;
T4 Lysozyme Mutant L99A/M102Q Bound by Phenolmonomer1-162
97.53CL;IPH;BME;
T4 LYSOZYME MUTANT C54T/C97A/L121A IN THE PRESENCE OF 8 ATM XENONmonomer1-162
96.91CL;XE;BME;
SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFEREN…monomer1-162
96.91CL;BME;
DESIGN AND STRUCTURAL ANALYSIS OF ALTERNATIVE HYDROPHOBIC CORE PACKING ARRANGEMENTS IN BACTERIOPHAG…monomer1-162
96.91CL;BME;
HYDROPHOBIC CORE REPACKING AND AROMATIC-AROMATIC INTERACTION IN THE THERMOSTABLE MUTANT OF T4 LYSOZ…monomer1-162
96.91PO4;CL;
T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 16 ATM ARGONmonomer1-162
96.91CL;AR;BME;
T4 LYSOZYME SUBSTITUTED WITH SELENOMETHIONINEmonomer1-162
93.21CL;HED;
High-pressure structure of pseudo-WT T4 Lysozymemonomer1-162
97.53CL;BME;
High-pressure structure of pseudo-WT T4 Lysozymemonomer1-162
97.53CL;BME;
METHIONINE CORE MUTANT OF T4 LYSOZYMEmonomer1-162
93.21CL;HED;
2-methoxyphenol in complex with T4 lysozyme L99A/M102Qmonomer1-162
96.3PO4;JZ3;BME;
N-TERMINAL DOMAIN CORE METHIONINE MUTATIONmonomer1-162
96.91CL;HED;
PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYMEmonomer1-162
97.53
T4 LYSOZYME MUTANT V103Mmonomer1-162
96.91CL;HED;
MULTIPLE STABILIZING ALANINE REPLACEMENTS WITHIN ALPHA-HELIX 126-134 OF T4 LYSOZYME HAVE INDEPENDEN…monomer1-162
96.3CL;BME;
METHIONINE CORE MUTANT OF T4 LYSOZYMEmonomer1-162
93.83CL;HED;
DESIGN AND STRUCTURAL ANALYSIS OF ALTERNATIVE HYDROPHOBIC CORE PACKING ARRANGEMENTS IN BACTERIOPHAG…monomer1-162
96.91CL;BME;
T4 LYSOZYME MUTANT L91Mmonomer1-162
96.91CL;HED;
N-TERMINAL DOMAIN CORE METHIONINE MUTATIONmonomer1-162
96.91CL;HED;
T4 lysozyme M102E/L99A mutant with buried charge in apolar cavity--ethylbenzene bindingmonomer1-162
93.83PYJ;ACT;
N-methylaniline in complex with T4 Lysozyme L99Amonomer1-162
96.91PO4;1MR;
DETERMINATION OF ALPHA-HELIX PROPENSITY WITHIN THE CONTEXT OF A FOLDED PROTEIN: SITES 44 AND 131 IN…monomer1-162
98.15CL;BME;
T4 LYSOZYME MUTANT C54T/C97A/L121A/L133A IN THE PRESENCE OF 8 ATM ARGONmonomer1-162
96.3CL;AR;BME;
T4 LYSOZYME MUTANT L91Amonomer1-162
96.91CL;HED;
DETERMINATION OF ALPHA-HELIX PROPENSITY WITHIN THE CONTEXT OF A FOLDED PROTEIN: SITES 44 AND 131 IN…monomer1-162
98.15CL;BME;
DETERMINATION OF ALPHA-HELIX PROPENSITY WITHIN THE CONTEXT OF A FOLDED PROTEIN: SITES 44 AND 131 IN…monomer1-162
98.15CL;BME;
Multiple Methionine Substitutions are Tolerated in T4 Lysozyme and have Coupled Effects on Folding …monomer1-162
91.36CL;HED;
T4 Lysozyme Cavity Mutant L99A/M102Q Bound with N-Allyl-Anilinemonomer1-162
97.53CL;BME;NYL;
ROLE OF BACKBONE FLEXIBILITY IN THE ACCOMMODATION OF VARIANTS THAT REPACK THE CORE OF T4 LYSOZYMEmonomer1-162
95.68CL;BME;
ROLE OF BACKBONE FLEXIBILITY IN THE ACCOMMODATION OF VARIANTS THAT REPACK THE CORE OF T4 LYSOZYMEmonomer1-162
95.06CL;BME;
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYMEmonomer1-162
96.91
THERMODYNAMIC AND STRUCTURAL COMPENSATION IN "SIZE-SWITCH" CORE-REPACKING VARIANTS OF T4 LYSOZYMEmonomer1-162
96.3CL;BME;
HOW AMINO-ACID INSERTIONS ARE ALLOWED IN AN ALPHA-HELIX OF T4 LYSOZYMEmonomer1-162
97.44CL;BME;
STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYMEmonomer1-162
96.91
T4 LYSOZYME MUTANT C54T/C97A/L99A/F153A IN THE PRESENCE OF 8 ATM KRYPTONmonomer1-162
96.3CL;KR;BME;
T4 Lysozyme mutant L99A at 200 MPamonomer1-162
96.91CL;BME;
T4 LYSOZYME MUTANT I78Amonomer1-162
96.91CL;HED;
High Pressure Psuedo Wild Type T4 Lysozymemonomer1-162
97.53CL;BME;
High-Pressure T4 Lysozymemonomer1-162
97.53CL;BME;
T4 LYSOZYME MUTANT V111Mmonomer1-162
96.91CL;HED;
DESIGN AND STRUCTURAL ANALYSIS OF ALTERNATIVE HYDROPHOBIC CORE PACKING ARRANGEMENTS IN BACTERIOPHAG…monomer1-162
95.06CL;BME;
T4 Lysozyme mutant L99A at 100 MPamonomer1-162
96.91CL;BME;
T4 Lysozyme mutant L99A at 100 MPamonomer1-162
96.91CL;BME;
T4 Lysozyme Cavity Mutant L99a/M102Q Bound With 2-Allylphenolmonomer1-162
97.53CL;2LP;BME;
T4 Lysozyme mutant L99A at 150 MPamonomer1-162
96.91CL;BME;
T4 LYSOZYME MUTANT C54T/C97A/L133A IN THE PRESENCE OF 8 ATM KRYPTONmonomer1-162
98.15CL;KR;BME;
T4 Lysozyme mutant L99A at 200 MPamonomer1-162
96.91CL;BME;
METHIONINE CORE MUTATIONmonomer1-162
94.44CL;HED;
T4 LYSOZYME MUTANT F104Mmonomer1-162
96.91CL;HED;
T4 LYSOZYME MUTANT V87Mmonomer1-162
96.91CL;HED;
PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYMEmonomer1-162
97.53
Crystal structure of phage T4 lysozyme mutant R14A/K16A/I17A/K19A/T21A/E22A/C54T/C97Amonomer1-162
93.83CL;BME;
T4 Lysozyme mutant L99A at 100 MPamonomer1-162
96.91CL;BME;
T4 lysozyme M102E/L99A mutant with buried charge in apolar cavity--phenol bindingmonomer1-162
93.83IPH;CL;CA;
METHIONINE CORE MUTANT OF T4 LYSOZYMEmonomer1-162
96.3CL;HED;
CONSERVATION OF SOLVENT-BINDING SITES IN 10 CRYSTAL FORMS OF T4 LYSOZYMEmonomer1-162
96.3PO4;
T4 LYSOZYME MUTANT C54T/C97A/L99A/F153A IN THE PRESENCE OF 8 ATM XENONmonomer1-162
96.3CL;XE;BME;
T4 Lysozyme mutant L99A at 200 MPamonomer1-162
96.91CL;BME;
T4 LYSOZYME MUTANT I78Mmonomer1-162
96.91CL;HED;
T4 LYSOZYME MUTANT C54T/C97A/L121A/L133A IN THE PRESENCE OF 8 ATM KRYPTONmonomer1-162
96.3CL;KR;BME;
T4 LYSOZYME MUTANT C54T/C97A/L133A IN THE PRESENCE OF 8 ATM XENONmonomer1-162
98.15CL;XE;BME;
T4 lysozyme M102E/L99A mutant with buried charge in apolar cavity--p-xylene bindingmonomer1-162
93.83PXY;CL;ACT;
THERMODYNAMIC AND STRUCTURAL COMPENSATION IN "SIZE-SWITCH" CORE-REPACKING VARIANTS OF T4 LYSOZYMEmonomer1-162
96.91CL;BME;
Crystal structure of spin labeled T4 Lysozyme (T151R1) at 291 Kmonomer1-162
96.91MTN;HED;CL;AZI;
T4 LYSOZYME MUTANT C54T/C97A/F153A IN THE PRESENCE OF 8 ATM XENONmonomer1-162
96.91CL;XE;BME;
T4 Lysozyme mutant L99A at ambient pressuremonomer1-162
96.91CL;BME;
T4 Lysozyme mutant L99A at ambient pressuremonomer1-162
96.91CL;BME;
T4 Lysozyme mutant L99A at ambient pressuremonomer1-162
96.91CL;BME;
THE INTRODUCTION OF STRAIN AND ITS EFFECTS ON THE STRUCTURE AND STABILITY OF T4 LYSOZYMEmonomer1-162
96.91HED;
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYMEmonomer1-162
96.91
T4 LYSOZYME MUTANT M106Kmonomer1-162
96.91CL;
STRUCTURAL CHARACTERISATION OF AN ENGINEERED TANDEM REPEAT CONTRASTS THE IMPORTANCE OF CONTEXT AND …monomer1-162
96.0
STRUCTURAL CHARACTERISATION OF AN ENGINEERED TANDEM REPEAT CONTRASTS THE IMPORTANCE OF CONTEXT AND …monomer1-162
96.0
Protein flexibility and adaptability seen in 25 crystal forms of T4 LYSOZYMEmonomer1-162
96.3
Long-Distance conformational changes in a protein engineered by modulated sequence duplicationmonomer1-162
95.68
THE INTRODUCTION OF STRAIN AND ITS EFFECTS ON THE STRUCTURE AND STABILITY OF T4 LYSOZYMEmonomer1-162
96.91CL;HED;
T4 LYSOZYME MUTANT C54T/C97A/L121A/L133A IN THE PRESENCE OF 8 ATM XENONmonomer1-162
96.3CL;XE;BME;
THE INTRODUCTION OF STRAIN AND ITS EFFECTS ON THE STRUCTURE AND STABILITY OF T4 LYSOZYMEmonomer1-162
96.91CL;HED;
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE…monomer1-162
96.3CL;HED;
PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYMEmonomer1-162
97.53
Use of sequence duplication to engineer a ligand-triggered long-distance molecular switch in T4 Lys…monomer1-162
96.1
Protein flexibility and adaptability seen in 25 crystal forms of T4 LYSOZYMEmonomer1-162
96.3CL;
HOW AMINO-ACID INSERTIONS ARE ALLOWED IN AN ALPHA-HELIX OF T4 LYSOZYMEmonomer1-162
97.53
The structure of T4 Lysozyme I3C/C54T/R125C/E128C complex with Zinc ionsmonomer1-162
96.3ZN;
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYMEmonomer1-162
93.83
Sequential reorganization of beta-sheet topology by insertion of a single strandmonomer1-162
97.42SO4;
T4 Lysozyme L99A/M102Q with Ethylbenzene Boundmonomer1-161
96.27PYJ;
T4-Lysozyme fusion to Geobacter GGDEFmonomer1-161
96.89GTP;GMP;POP;MG;GOL;ACT;
T4 Lysozyme L99A/M102Q with Benzene Boundmonomer1-161
96.27BNZ;
T4 Lysozyme L99A/M102Q with 1-Hydro-2-ethyl-1,2-azaborine Boundmonomer1-161
96.27CL;6OQ;
Crystal Structure of the Cannabinoid Receptor 1 Interacting Protein 1a (CRIP1a)monomer1-161
98.51
T4 Lysozyme L99A with 1-Hydro-2-ethyl-1,2-azaborine Boundmonomer1-161
96.896OQ;CL;
T4 Lysozyme L99A/M102Q with 1,2-Dihydro-1,2-azaborine Boundmonomer1-161
96.27B20;CL;
Crystal Structure of mGluR5 in complex with MMPEP at 2.2 Amonomer2-162
97.52OLA;MES;D8B;
Structure of EspG1 chaperone from the type VII (ESX-1) secretion system determined with the assista…monomer2-162
96.89CL;
High resolution crystal structure of human B2-adrenergic G protein-coupled receptor.monomer2-162
97.52GLC;SO4;CAU;BU1;ACM;CLR;PLM;12P;
In meso in situ serial X-ray crystallography structure of the Beta2-adrenergic receptor at 100 Kmonomer2-162
97.52BGC;CAU;BU1;ACM;CLR;PLM;12P;SO4;
thermostabilised 7TM domain of human mGlu5 receptor bound to photoswitchable ligand alloswitch-1monomer2-162
97.524YI;
Structure of the human class C GPCR metabotropic glutamate receptor 5 transmembrane domain in compl…monomer2-162
97.52OLA;2U8;MES;
Structure of the human class C GPCR metabotropic glutamate receptor 5 transmembrane domain in compl…monomer2-162
97.52OLA;51E;
Crystal Structure of mGluR5 in complex with Fenobam at 2.65 Amonomer2-162
97.52OLA;MES;D7W;OLC;
The Crystal Structure of human neuropeptide Y Y1 receptor with UR-MK299monomer1-161
97.459AO;
Structure of beta2 adrenoceptor bound to carazolol and an intracellular allosteric antagonistmonomer2-162
97.52EPE;CLR;8VS;CAU;BU1;ACM;
Cholesterol bound form of human beta2 adrenergic receptor.monomer2-162
97.52TIM;CLR;OLC;
Structure of CC Chemokine Receptor 2 with Orthosteric and Allosteric Antagonistsmonomer3-163
96.2773R;VT5;SO4;OLC;ZN;
Crystal structure of the human beta2 adrenergic receptor in complex with the inverse agonist ICI 11…monomer2-162
97.52CLR;JRZ;OLA;OLC;PGE;
Crystal structure of the human beta2 adrenergic receptor in complex with a novel inverse agonistmonomer2-162
97.52CLR;JSZ;OLC;
Structure of the D2 Dopamine Receptor Bound to the Atypical Antipsychotic Drug Risperidonemonomer2-162
97.58NU;PEG;OLA;
Structure of the human class C GPCR metabotropic glutamate receptor 5 transmembrane domain in compl…monomer2-162
97.52OLA;MES;51D;
Crystal structure of the human beta2 adrenergic receptor in complex with the neutral antagonist alp…monomer2-162
97.52CLR;JTZ;
beta2AR-T4L - CIMmonomer2-162
97.52BGC;SO4;CAU;BU1;ACM;CLR;PLM;12P;
Crystal structure of the N-terminal domain of Atg2monomer1-161
96.89
Structure of the M3 Muscarinic Acetylcholine Receptormonomer1-161
97.520HK;PO4;
Irreversible Agonist-Beta2 Adrenoceptor Complexmonomer2-162
97.52ERC;CLR;SO4;
Structure of the M3 muscarinic acetylcholine receptor bound to the antagonist tiotropium crystalliz…monomer1-161
96.270HK;
In meso X-ray crystallography structure of the Beta2-adrenergic receptor at 100 Kmonomer2-162
97.52BGC;CAU;BU1;ACM;CLR;PLM;SO4;
Structure of M1-StaR-T4L in complex with 77-LH-28-1 at 2.17Amonomer2-161
97.5QJT;OLA;PO4;OLC;EPE;PGE;
GPR40 in complex with partial agonist MK-8666monomer2-161
97.5NA;MK6;MLI;OLC;1PE;
Crystal structure of human protease-activated receptor 1 (PAR1) bound with antagonist vorapaxar at …monomer2-161
96.88VPX;OLC;CL;NA;
Crystal structure of PH domain of Osh3 from Saccharomyces cerevisiaemonomer2-161
96.88SO4;
Structure of M1-StaR-T4L in complex with HTL0009936 at 2.35Amonomer2-161
97.5QK8; 11×OLA;PGE;PO4;
Crystal structure of Human GPR40 bound to allosteric agonist TAK-875monomer2-161
97.52YB;OLC;1PE;DMS;
Crystal structure of the PH-like domain of Lam6monomer2-161
96.812PE;
Complex structure of CSN2 with IP6monomer2-161
97.5IHP;SO4;
Crystal structure of EP3 receptor bound to misoprostol-FAmonomer2-161
96.88J9P;SO4;OLC;OLA;
Crystal structure of the cholecystokinin receptor CCKAR in complex with devazepidemonomer2-161
97.51OZ;
Structure of M1-StaR-T4L in complex with GSK1034702 at 2.5Amonomer2-161
97.5QK2;EPE;OLA;PO4;
The 2.6 A Crystal Structure of a Human A2A Adenosine Receptor bound to ZM241385.monomer2-161
97.5ZMA;STE;SO4;
Agonist bound human A2a adenosine receptor with D52N mutation at 2.60 A resolutionmonomer2-161
97.5UKA;OLC;
Crystal structure of the PE-bound N-terminal domain of Atg2monomer2-161
96.88PEE;
Structure of the human M1 muscarinic acetylcholine receptor bound to antagonist Tiotropiummonomer2-161
1000HK;Y01;EDO;PGE;GOL;
Structure of the human GLP-1 receptor complex with PF-06372222monomer2-161
97.597Y;OLC;OLA;
Agonist bound structure of the human adenosine A2a receptormonomer2-161
97.5UKA;OLC;
The extra-helical binding site of GPR40 and the structural basis for allosteric agonism and increti…monomer2-161
97.56XQ;
Crystal structure of the cholecystokinin receptor CCKAR in complex with lintitriptmonomer2-161
97.51OE;
Structure of thermal-stabilised(M9) human GLP-1 receptor transmembrane domainmonomer2-161
97.597Y;OLC;
Crystal Structure of a Lipid G protein-Coupled Receptor at 2.80Amonomer2-161
97.5ML5;NAG;
Structure of thermal-stabilised(M8) human GLP-1 receptor transmembrane domainmonomer2-161
97.597Y;
Crystal structure of a thermostabilised human protease-activated receptor-2 (PAR2) in complex with …monomer2-161
97.58TZ;NA;PO4;
Structure of the human dopamine D3 receptor in complex with eticlopridemonomer2-161
97.5GLC;ETQ;
Agonist bound human A2a adenosine receptor with S91A mutation at 2.90 A resolutionmonomer2-161
97.5UKA;OLC;
Crystal structure of human corticotropin-releasing factor receptor 1 (CRF1R) in complex with the an…monomer2-161
95.621Q5;OLA;OLC;SO4;
Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonistmonomer2-161
97.5QNB;BGC;CL;
Structure of the human GLP-1 receptor complex with NNC0640monomer2-161
97.597V;
Crystal structure of the cholecystokinin receptor CCKAR in complex with NN9056monomer2-161
97.5
Crystal structure of rhodopsin bound to visual arrestin determined by X-ray free electron lasermonomer2-161
97.5NAG;
Structure of the human histamine H1 receptor in complex with doxepinmonomer2-161
97.785EH;D7V;PO4;OLC;
Structure of thermal-stabilised(M6) human GLP-1 receptor transmembrane domainmonomer2-161
97.597Y;
Structure of human beta2 adrenergic receptor bound to constrained epinephrinemonomer2-161
97.5G1I;NA;
Crystal structure of zebrafish lysophosphatidic acid receptor LPA6monomer2-161
96.25OLC;
Crystal structure of an agonist bound GPCRmonomer2-161
97.5E3R;
GPR40 in complex with AgoPAM AP8 and partial agonist MK-8666monomer2-161
97.16OLC;MK6;7OS;
Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray lasermonomer2-161
97.5
Crystal Structure of a Lipid G protein-Coupled Receptor at 3.35Amonomer2-161
97.5ML5;NAG;
Structure of the delta opioid receptor bound to naltrindolemonomer2-161
96.88EJ4;
Structure of human beta2 adrenergic receptor bound to constrained isoproterenolmonomer2-161
97.5GJ6;NA;
Crystal structure of a thermostabilised human protease-activated receptor-2 (PAR2) in complex with …monomer2-161
97.338UN;NA;
Crystal Structure of human mARC1monomer1-159
98.74MTE;EFK;B3P;MOO;PO4;
Crystal structure of the human glucagon receptor (GCGR) in complex with the antagonist MK-0893monomer2-160
97.445MV; 14×OLA;PE5;TLA;
The Crystal Structure of Human Neuropeptide Y Y1 Receptor with BMS-193885monomer3-161
97.489AF;
Crystal structure of the dynein motor domain in the AMPPNP-bound statemonomer4-161
97.47ANP;MG;
Circular permutation of Helix A in T4 lysozymemonomer13-163
98.01
Truncated and mutated T4 lysozymemonomer61-163
91.26NI;
Human endothelin receptor type-B in complex with antagonist K-8794monomer61-161
98.02K87; 11×OLC;CLR;SO4;
Human endothelin receptor type-B in the ligand-free formmonomer61-161
98.02SO4;OLC;OLA;
Structure of the M4 muscarinic acetylcholine receptor (M4-mT4L) bound to tiotropiummonomer61-161
98.00HK;OLA;EDT;P6G;OLC;
Human endothelin receptor type-B in complex with inverse agonist IRL2500monomer61-161
97.98D2U;PO4;OLC;
Crystal structure of the human NK1 substance P receptormonomer61-161
98.02GBQ;
Crystal structure of the prostaglandin D2 receptor CRTH2 with CAY10471monomer61-161
98.02SO4;FT4;MES;OLA;PGE;PGO;PEG;
Crystal structure of the prostaglandin D2 receptor CRTH2 with fevipiprantmonomer61-161
98.02FSY;SO4;SIN;PGE;OLA;PGO;
Crystal structure of the human NK1 substance P receptormonomer61-161
98.02GBQ;OLC;
Human endothelin receptor type-B in complex with antagonist bosentanmonomer61-161
97.89K86;SO4;
M3 muscarinic acetylcholine receptor in complex with a selective antagonistmonomer62-161
98.0GLC;PG4;9EC;
Computational design of highly signaling active membrane receptors through de novo solvent-mediated…monomer68-164
97.94NGI;

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
1l17.1.Amonomer0.921-164
98.17